Cincinnati startup licenses technology invented by renowned children ’s hospital
Blue Water Vaccines Inc., a Norwood startup, has entered into an exclusive worldwide license agreement with St. Jude Children ’s Research Hospital to develop a vaccine for Streptococcus pneumoniae. The bacteria can cause many kinds of diseases, including the lung infection pneumonia.
“A major limitation of the currently licensed pneumococcal vaccines is the lack of efficacy against mucosal disease manifestations such as acute otitis media, acute bacterial sinusitis and pneumonia,” Blue Water… (Source: bizjournals.com Health Care:Pharmaceuticals headlines)
Source: bizjournals.com Health Care:Pharmaceuticals headlines - February 10, 2020 Category: Pharmaceuticals Authors: Barrett J. Brunsman Source Type: news
Hexavalent Vaccine Included in Vaccines for Children Program
FRIDAY, Feb. 7, 2020 -- The hexavalent combined diphtheria and tetanus toxoids and acellular pertussis (DTaP) adsorbed, inactivated poliovirus (IPV), Haemophilus influenza type b (Hib) conjugate (meningococcal protein conjugate), and hepatitis B... (Source: Drugs.com - Pharma News)
Source: Drugs.com - Pharma News - February 7, 2020 Category: Pharmaceuticals Source Type: news
Pneumococcal vaccines are effective -- But new strategies needed to reduce meningitis
(Wolters Kluwer Health) Pneumococcal conjugate vaccines (PCVs) have been highly effective in reducing pneumonia and other invasive infections caused by Streptococcus pneumoniae bacteria. But rates of meningitis have shown little change, as pneumococcal strains not targeted by PCVs emerge as more important causes of meningitis, reports a paper in The Pediatric Infectious Disease Journal, the official journal of The European Society for Paediatric Infectious Diseases. The journal is published in the Lippincott portfolio by Wolters Kluwer. (Source: EurekAlert! - Medicine and Health)
Source: EurekAlert! - Medicine and Health - February 7, 2020 Category: International Medicine & Public Health Source Type: news
New research into how peace of mind can influence parents' attitude to vaccines
(Meningitis Research Foundation) Research from Bristol University on parents' peace of mind and vaccinations gives us insight that beliefs about vaccines can change, and that peace of mind varies according to different factors. The MenB vaccine, although considered 'new' provided increased reassurance because of the perceived disease severity. Meningitis Research Foundation says parents' peace of mind is currently being ignored when health bodies weigh up vaccine benefits to make decisions whether to introduce vaccines or expand their coverage. (Source: EurekAlert! - Social and Behavioral Science)
Source: EurekAlert! - Social and Behavioral Science - February 4, 2020 Category: International Medicine & Public Health Source Type: news
Updated Pneumococcal Vaccine Recommendations for Older Adults Updated Pneumococcal Vaccine Recommendations for Older Adults
What do the new PCV13 recommendations mean, and how do you implement them in your practice? Here ' s what you need to know.CDC Expert Commentary (Source: Medscape Allergy Headlines)
Source: Medscape Allergy Headlines - January 31, 2020 Category: Allergy & Immunology Tags: Infectious Diseases Commentary Source Type: news
New study confirms success of MenB vaccine in the UK
MenB vaccination programme has reduced cases of meningitis and septicaemia in young children by almost two-thirds. (Source: Current Awareness Service for Health (CASH))
Source: Current Awareness Service for Health (CASH) - January 31, 2020 Category: Consumer Health News Source Type: news
MenB vaccination programme evaluation
Public Health England has announced that the MenB vaccination programme has reduced cases of meningitis and septicaemia in young children by almost two-thirds. (Source: Current Awareness Service for Health (CASH))
Source: Current Awareness Service for Health (CASH) - January 29, 2020 Category: Consumer Health News Source Type: news
PNEUMOSIL ® , the new pneumococcal vaccine, achieves WHO...
Leaders from PNEUMOSIL® collaborators—the Serum Institute of India and the Bill & Melinda Gates Foundation—to speak at the first-ever Global Forum on Childhood Pneumonia on January 29-31,...(PRWeb January 28, 2020)Read the full story at https://www.prweb.com/releases/pneumosil_the_new_pneumococcal_vaccine_achieves_who_prequalification_a_key_step_toward_improving_access_and_affordability/prweb16866771.htm (Source: PRWeb: Medical Pharmaceuticals)
Source: PRWeb: Medical Pharmaceuticals - January 28, 2020 Category: Pharmaceuticals Source Type: news
New study confirms success of MenB vaccine in the UK
MenB vaccination programme has reduced cases of meningitis and septicaemia in young children by almost two-thirds. (Source: NHS Networks)
Source: NHS Networks - January 23, 2020 Category: UK Health Source Type: news
Outbreaks of severe pneumococcal disease in closed settings in the conjugate vaccines era, 20102018: A systematic review to inform national guidance in the UK.
Pneumococcal outbreaks are rare but they still occur, particularly in closed settings usually involving vulnerable groups. The authors undertook a systematic review to identify strategies for controlling pneumococcal outbreaks since the licensure of higher-valent pneumococcal conjugate vaccines (PCVs). (Source: Current Awareness Service for Health (CASH))
Source: Current Awareness Service for Health (CASH) - January 16, 2020 Category: Consumer Health News Source Type: news
Erratum: Vol. 68, No. 46
In the report " Use of 13-Valent Pneumococcal Conjugate Vaccine and 23-Valent Pneumococcal Polysaccharide Vaccine Among Adults Aged ≥65 Years: Updated Recommendations of the Advisory Committee on Immunization Practices, " on page 1074... (Source: CDC Morbidity and Mortality Weekly Report)
Source: CDC Morbidity and Mortality Weekly Report - January 2, 2020 Category: American Health Tags: MMWR Morbidity & Mortality Weekly Report Source Type: news
Kids With Asthma at Greater Risk for Pneumococcal Disease Kids With Asthma at Greater Risk for Pneumococcal Disease
Children with asthma were at increased risk for pneumococcal disease, even those who had been vaccinated, a study found.Medscape Medical News (Source: Medscape Medical News Headlines)
Source: Medscape Medical News Headlines - December 19, 2019 Category: Consumer Health News Tags: Pediatrics News Source Type: news
Dr. John Robbins, Developer of a Meningitis Vaccine, Dies at 86
His method of boosting immune protection in babies helped save seven million lives. But he never profited from it. (Source: NYT Health)
Source: NYT Health - December 18, 2019 Category: Consumer Health News Authors: Donald G. McNeil Jr. Tags: John B. Robbins Deaths (Obituaries) Vaccination and Immunization Inventions and Patents Children and Childhood Haemophilus influenzae type b (Hib) Food and Drug Administration National Institutes of Health Meningitis Source Type: news
Pneumococcal 13-valent polysaccharide vaccination (PCV13) response in patients with pulmonary aspergillosis
Conference abstracts (Source: The Aspergillus Website - updates)
Source: The Aspergillus Website - updates - December 12, 2019 Category: Respiratory Medicine Authors: MeganB Source Type: news
New Recommendations for Pneumococcal Vaccine in Older Adults New Recommendations for Pneumococcal Vaccine in Older Adults
Review recent changes in ACIP ' s recommendations for pneumococcal conjugate vaccine use in older adults.Morbidity & Mortality Weekly Report (Source: Medscape Allergy Headlines)
Source: Medscape Allergy Headlines - December 11, 2019 Category: Allergy & Immunology Tags: Public Health & Prevention Journal Article Source Type: news
